top of page

SPORT GENOMICS - Giordano: "On the Field to Prevent Illnesses Like Bove's with Genetic Predictions, but 20% of Life Events Remain an Unpredictable Enigma.

Over 100 Saliva Samples Collected from Fiorentina with the Sport Genomics Project

Antonio Giordano in a lab setting, reviewing genetic data and collaborating with researchers, symbolizing his innovative work in Sport Genomics for athlete health and Cancer Deflect for early cancer diagnosis
Antonio Giordano leading groundbreaking initiatives in Sport Genomics and Cancer Deflect, revolutionizing athlete health and early cancer detection through precision medicine.

The Sport Genomics project is working to prevent illnesses like those faced by Fiorentina footballer Edoardo Bove, to whom we extend our deepest support and solidarity. Despite advancements in genetic predictions, it’s important to acknowledge that 20% of life events remain an unpredictable enigma—true acts of destiny.


Antonio Giordano, oncologist, pathologist, and President of the Sbarro Institute at Temple University, spearheads the Sport Genomics initiative. This precision medicine project focuses on the early identification of genetic vulnerabilities that could predispose athletes to illnesses and injuries. By using genetic screening from saliva samples, the project aims to implement personalized training programs and dietary-nutritional strategies tailored to individual needs.


To date, over 100 saliva samples have been collected in collaboration with Fiorentina AC and are currently under analysis. Additional agreements have been made with Asti Futsal (Serie A five-a-side football) and Real Società Ginnastica di Torino's basketball section. These partnerships aim to expand the pool of analyzed samples, particularly from youth athletes of both genders in the Piedmont region.


In parallel, another precision medicine initiative, Cancer Deflect, offers the possibility of early lung cancer diagnosis with enhanced long-term prognostic capabilities. This project builds on prior work between Rigenera and the University of Siena, led by Professor Giordano. Using the HBW surgical device, researchers identify a subpopulation of cancer stem cells within lung tumor biopsies, which can then undergo detailed molecular analysis.


Through these cutting-edge approaches, both projects strive to advance health and well-being in sports and medicine, while acknowledging the limits of science in navigating the unpredictable aspects of life.


Professor Antonio Giordano, M.D., Ph.D., is the creator and head of the Sbarro Health Research Organization, located at Temple University's College of Science and Technology in Philadelphia. Stay connected with him through his various social media platforms, including Facebook, LinkedIn, Twitter, and Instagram, to receive the latest updates.

Comments


bottom of page